Circulatory levels of catecholamines, serotonin and lipids in attention deficit hyperactivity disorder.

scientific article published in April 1999

Circulatory levels of catecholamines, serotonin and lipids in attention deficit hyperactivity disorder. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/J.1600-0447.1999.TB07229.X
P698PubMed publication ID10223434
P5875ResearchGate publication ID227831435

P50authorAbraham WeizmanQ27020194
P2093author name stringGraf E
Mester R
Spivak B
Vered Y
Yoran-Hegesh R
Averbuch E
P2860cites workMethylphenidate response in aggressive and nonaggressive ADHD children: distinctions on laboratory measures of symptomsQ41115786
A self-report measure of violence risk, II.Q41184471
Blood platelet uptake of serotonin in episodic aggressionQ41350601
The neurobiology of suicideQ41680290
Personality profiles and state aggressiveness in Finnish alcoholic, violent offenders, fire setters, and healthy volunteersQ47927292
Selective brain dopamine depletion in developing rats: an experimental model of minimal brain dysfunctionQ48406779
A 2-year prospective follow-up study of children and adolescents with disruptive behavior disorders. Prediction by cerebrospinal fluid 5-hydroxyindoleacetic acid, homovanillic acid, and autonomic measures?Q52043522
Cerebrospinal fluid monoamine metabolites, aggression, and impulsivity in disruptive behavior disorders of children and adolescents.Q52058162
P433issue4
P407language of work or nameEnglishQ1860
P921main subjectattention deficit hyperactivity disorderQ181923
serotoninQ167934
P304page(s)300-304
P577publication date1999-04-01
P1433published inActa Psychiatrica ScandinavicaQ4033348
P1476titleCirculatory levels of catecholamines, serotonin and lipids in attention deficit hyperactivity disorder.
P478volume99

Reverse relations

cites work (P2860)
Q43880347Association of attention deficit hyperactivity disorder-related psychopathology and personality traits with the serotonin transporter promoter region polymorphism
Q56515589Attention deficit-hyperactivity disorder is associated with allergic symptoms and low levels of hemoglobin and serotonin
Q48118813Attention switching after dietary brain 5-HT challenge in high impulsive subjects
Q24671982Behavioral models of impulsivity in relation to ADHD: translation between clinical and preclinical studies
Q35165422Brain sites of movement disorder: genetic and environmental agents in neurodevelopmental perturbations
Q22252698Candidate gene studies of ADHD: a meta-analytic review
Q35808544Corticosteroids, depression and the role of serotonin
Q48933564Development of an LC-MS/MS method for the analysis of serotonin and related compounds in urine and the identification of a potential biomarker for attention deficit hyperactivity/hyperkinetic disorder
Q48493702Disorder-dissociated effects of fluoxetine on brain function of working memory in attention deficit hyperactivity disorder and autism spectrum disorder
Q31139642Effects of nicotine on neurodevelopment
Q33703998Electrophysiological markers of genetic risk for attention deficit hyperactivity disorder
Q51973109Evidence for the serotonin HTR2A receptor gene as a susceptibility factor in attention deficit hyperactivity disorder (ADHD).
Q46949050Exploration of 19 serotoninergic candidate genes in adults and children with attention-deficit/hyperactivity disorder identifies association for 5HT2A, DDC and MAOB.
Q43276216Further evidence for the association between attention deficit/hyperactivity disorder and the serotonin receptor 1B gene
Q35693662Inverse Effect of Fluoxetine on Medial Prefrontal Cortex Activation During Reward Reversal in ADHD and Autism
Q35607540Inverse fluoxetine effects on inhibitory brain activation in non-comorbid boys with ADHD and with ASD.
Q39182333New marker using bioimpedance technology in screening for attention deficit/hyperactivity disorder (ADHD) in children as an adjunct to conventional diagnostic methods
Q48863476Overcrowding induces anxiety and causes loss of serotonin 5HT-1a receptors in rats
Q43773764Pediatric migraine prophylaxis with divalproex
Q64889147Recent Trends in the Quantification of Biogenic Amines in Biofluids as Biomarkers of Various Disorders: A Review.
Q36972698Role of the serotonin system in ADHD: treatment implications
Q49094157The effects of acute fluoxetine administration on temporal discounting in youth with ADHD.
Q48458583The influence of three months of methylphenidate treatment on platelet-poor plasma biogenic amine levels in boys with attention deficit hyperactivity disorder.
Q34444941Transmission disequilibrium of polymorphic variants in the tryptophan hydroxylase-2 gene in attention-deficit/hyperactivity disorder